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Our ability to survive requires the competency to control infection. In the last 50 years, there has been
an explosion in our understanding of the processes that underlie this. Central to this is our ability
to restrict the infection to local sites and so prevent it from becoming systemic. Infections caused
by serovars of the species Salmonella enterica, spread through fecal–oral transmission, exemplify
this and are a major reason why this organism was chosen as the theme of this Research Topic.
Salmonella infections, particularly typhoidal infections, have had their hand on the tiller of human
history, able to steer fate in new directions as a consequence of their deadly properties. A key element
of this is the ability to spread through the host and this is often associated with the capacity to
cause fatal infections. The prevention of infection and the control of bacterial spread require the
complex interplay between themicrobiota and innate and adaptive immunemechanisms. The effects
of Salmonella infections on the complex systems that regulate their control can leave short- and
long-term footprints on the homeostatic functions of the host, for instance in the thymus and bone
marrow (1, 2), broadens the significance of their study. The depth of interest in this organism is
represented in this Research Topic.
The reasons behind the diverse clinicalmanifestations of this infection are introduced byGal-Mor
and colleagues (3), who discuss the differences between typhoidal and non-typhoidal Salmonella
strains. This overview includes introducing antigens, including Vi capsule, which can be differen-
tially expressed, as well as the distinct immune responses induced by different serovars. Whilst most
groups focus their studies on Salmonella infections in mammalian hosts, it should be remembered
that many serovars can colonize other organisms too, and indeed this provides a reservoir for most
non-typhoidal strains.Wigley highlights the importance of Salmonella infection in chickens, both as
a source of zoonotic infection, but also as a disease in itself and one of major economic importance
(4). Furthermore, we can learn so much from this system, for instance chickens lack lymph nodes,
have different MHC and TLR usage, and lack IgG subclasses, so the regulation of the immune
response is likely to have multiple unique features. Although the severity of Salmonella infections
in humans and mice is associated with its systemic spread, there is obviously a close relationship
with the gut, well described as “a mucosal pathogen with a systemic agenda” (5). In immunological
terms, this is a fascinating relationship to study. Inmanyways, a primary aimof themucosal system is
to limit inflammation to maintain barrier integrity, whereas systemic immunity often dramatically
exploits inflammation to contain infection. This is neatly exploited by non-typhoidal Salmonella
strains that are commonly associated with gastrointestinal infection and inflammation. In addition,
Vi-expressing S. Typhi may also exploit lower levels of mucosal inflammation to help it spread
throughout the host (6). Several works in this edition refer to relationship between the pathogen
and the gut. Santos examines the three-way relationship between Salmonella, the microbiota, and
the innate immune system, with a particular emphasis on how the microbiota can buffer against
infection (7). Patel and McCormick further develop this concept to encompass details on the ability
of Salmonella to exploit innate barriers and immune cells via type III secretion systems to establish
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and cause infections (8). This theme is explored in greater depth
from a Salmonella perspective by Hurley and colleagues (9), who
provide insights into the repertoire of virulence-associated genes
used by Salmonella during infection. Salmonella pathogenicity
islands (SPI) are important foci of genes that contribute to vir-
ulence. How expression of genes within these SPI is controlled
is incompletely understood, particularly for the regulation of
expression by transcriptional factors encoded outside the regions
themselves. Guadarrama and colleagues discuss the potential role
of the transcriptional global regulator LeuO in this process (10).
More details of innate-like immune cells at the gut mucosa, and
how they function, are provided byUssher et al. (11), who describe
the known and potential roles of mucosal-associated innate-like
T cells in Salmonella and other infections. One important mecha-
nism used to control intracellular survival, for instance through
sensing for bacteria, is the ubiquitin pathway, control of which
is a melee which ensues between the host and pathogen. How
the host uses this pathway and how Salmonella impacts upon it
is the subject of a review by Narayanan and Edelmann (12) and
they also describe how understanding these interactions helps
improve our comprehension of the ubiquitin pathway in health
in addition to disease. The reasons underlying genetic suscep-
tibility to Salmonella infections are multiple and complex. In a
primary research paper, Khan et al. describe susceptibility loci in
a non-standard mouse model derived from wild mice (13). This
work characterizes the immunity to typhimurium 3 (ity3) locus
in greater detail to understand the nature of resistance to this
infection.
When barriers and innate immunity are insufficient to control
infection in mice and humans, then adaptive immunity, includ-
ing T cells and antibody responses, can contribute to pathogen
control to varying degrees. A number of papers in this Research
Topic examine the role of adaptive immune responses in the
generation of immunity to Salmonella and different strategies
for vaccine development. O’Donnell and McSorley (14) expand
our current appreciation of the role of T cells against bacteria.
They do this by examining the development of classical T helper
1 responses to bacterial antigens, but also examine innate-like
T cell activation and bystander T cell activation. Furthermore,
they discuss the roles and importance of these cells and how
infection can subvert their activities. CD4 T cells and the Th1
cells are most associated with control of Salmonella infections.
Nevertheless, CD8 T cells and B cells are likely to be impor-
tant too. The relationship between these latter two cell types
is examined by Lopez-Medina and colleagues (15). They assess
whether infection of B cells results in cross-talk between these
cells and CD8 T cells and the potential for this to influence
the generation of immunity. This has not been widely explored
in the literature and may indicate a role of B cells for aiding
in the dissemination of infection. A broad assessment of the
immune response to typhoid in humans is provided by Sztein
and colleagues (16) and covers T and B cell responses to active
infection and the major antigens recognized by the host during
infection. A key focus of this study and the central point of the
article by Jones et al. is the reintroduction of the human chal-
lenge model for typhoid (17, 18). The ability to know the exact
time an individual is infected overcomes a major complication
in the study of this disease, which is identifying the stage after
infection a response is being measured. This should help to iden-
tify improved ways to diagnose infection and protect against it
through vaccination.
Typhoid is unusual in that there are three vaccines that provide
similar protection against disease, albeit that the protection is
limited and relatively short-lived, reflecting the efforts employed
to limit its spread. Bumann, MacLennan, and Sztein et al. (16,
19, 20) examine the mechanisms of protection against infection
through vaccination. Sztein et al. describe many studies using
live-attenuated vaccines against typhoid, the lessons that have
been learned and the potential for conjugate vaccines generated
around the Vi antigen. Bumann focuses on identifying the prop-
erties of antigens and how to identify those with the potential to
make successful subunit vaccines from the many thousands of
antigens that constitute this pathogen. Finally, the article from
MacLennan also highlights that multiple antigens are likely to
be targets of protective antibody and that this can be harnessed
for vaccination. Nevertheless, this article also draws attention to
the consequences of inappropriate levels of antibody responses
that can turn a protective response to one that may actually be
detrimental. Collectively, these three contributions highlight the
challenges that we face to make effective vaccines to Salmonella
infections.
This Research Topic has articles that consider the fundamental
nature of Salmonella infections from the first principles of why
one particular serovar causes one infection and a different one
a distinct disease, all the way through to the nature of classical
immunomodulation of the host through vaccination. Such a spec-
trum of offerings will help us better understand the nature of this
pathogen and how it can control us and how we can control it.
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